Xu He Selected Research

Xu He Research Topics

Disease

43	Neoplasms (Cancer) 02/2022 - 05/2002
18	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 04/2012
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 03/2009
8	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2002
7	Thrombosis (Thrombus) 01/2022 - 03/2009
6	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2019 - 01/2012
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2008
5	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2002
4	Inflammation (Inflammations) 01/2022 - 01/2018
4	Hypertension (High Blood Pressure) 01/2020 - 09/2013
4	Carcinogenesis 06/2015 - 09/2014
3	Pain (Aches) 06/2022 - 06/2012
3	Cataract (Cataracts) 01/2022 - 08/2017
3	Ischemia 01/2022 - 09/2015
3	Arteriovenous Fistula 06/2021 - 04/2019
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 11/2018
3	Pathologic Constriction (Stenosis) 01/2020 - 02/2005
3	Mucopolysaccharidoses 12/2019 - 12/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 11/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 02/2009
3	Esophageal Squamous Cell Carcinoma 01/2018 - 01/2009
3	Mucopolysaccharidosis I (Hurler Syndrome) 12/2017 - 01/2012
3	Autoimmune Diseases (Autoimmune Disease) 11/2014 - 03/2013
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2013 - 01/2012
2	Hemorrhage 10/2022 - 02/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 01/2020
2	Insulin Resistance 04/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 01/2018
2	Infections 01/2022 - 01/2021
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2020
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 05/2010
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 01/2021
2	Adenocarcinoma of Lung 01/2022 - 02/2016
2	Varicose Veins (Varicose Vein) 01/2022 - 01/2021
2	Proteinuria 01/2022 - 01/2020
2	COVID-19 12/2021 - 05/2021
2	Pulmonary Embolism 04/2021 - 02/2011
2	Glomerulonephritis 01/2021 - 01/2020
2	Aneurysm (Aneurysms) 01/2021 - 01/2016
2	Neuroinflammatory Diseases 01/2021 - 11/2018
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2015
2	Liver Neoplasms (Liver Cancer) 10/2020 - 01/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 04/2019
2	Emphysema 11/2019 - 06/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 09/2014
2	Carcinoma (Carcinomatosis) 12/2016 - 07/2015
2	Melanoma (Melanoma, Malignant) 11/2016 - 04/2013
2	Hyperplasia 11/2014 - 02/2005

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2012
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
8	Messenger RNA (mRNA)IBA 01/2020 - 05/2002
7	Pharmaceutical PreparationsIBA 02/2022 - 02/2005
6	AntigensIBA 01/2020 - 12/2016
6	Iduronidase (alpha-L-Iduronidase)IBA 12/2019 - 01/2012
6	Sorafenib (BAY 43-9006)FDA Link 12/2019 - 04/2012
6	EnzymesIBA 01/2018 - 05/2010
5	AutoantibodiesIBA 01/2020 - 12/2016
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2019 - 05/2010
5	MicroRNAs (MicroRNA)IBA 01/2015 - 05/2013
4	Biological ProductsIBA 01/2022 - 11/2014
4	CytokinesIBA 01/2022 - 11/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2007
4	SurvivinIBA 01/2019 - 11/2008
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2014 - 10/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019 - 01/2015
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2019 - 12/2016
3	ImmunosorbentsIBA 01/2018 - 05/2010
2	glubran 2IBA 10/2022 - 01/2021
2	LipidsIBA 04/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	AntibodiesIBA 01/2021 - 09/2013
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020 - 06/2013
2	Therapeutic UsesIBA 07/2020 - 09/2013
2	Phenobarbital (Luminal)FDA Link 04/2020 - 01/2020
2	SmokeIBA 11/2019 - 06/2015
2	Estrogen ReceptorsIBA 05/2019 - 06/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 02/2005
2	Long Noncoding RNAIBA 01/2019 - 08/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2017 - 05/2010
2	Peptides (Polypeptides)IBA 01/2017 - 03/2013
2	thiamine triphosphorate (TTP)IBA 06/2016 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 05/2002
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2014 - 12/2013

Therapy/Procedure

15	Therapeutics 02/2022 - 05/2010
8	Catheters 01/2022 - 07/2005
7	Stents 10/2020 - 02/2005
5	Thrombectomy 01/2022 - 03/2009
3	Immunotherapy 01/2022 - 05/2010
3	Renal Dialysis (Hemodialysis) 06/2021 - 02/2018
3	Enzyme Replacement Therapy 12/2017 - 01/2012
2	Punctures 06/2022 - 11/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 01/2019
2	Vena Cava Filters (Inferior Vena Cava Filter) 01/2022 - 03/2009
2	Radiotherapy 05/2021 - 11/2019
2	Lasers (Laser) 01/2021 - 10/2017
2	Mesenchymal Stem Cell Transplantation 11/2019 - 06/2015
2	Radiofrequency Ablation 01/2018 - 12/2013
2	Phacoemulsification 10/2017 - 08/2017